Home
Conditions
Epstein-Barr Virus Infections

Clinical trial condition

Epstein-Barr Virus Infections

Explore clinical trials studying Epstein-Barr Virus Infections. Study availability and eligibility vary by location and protocol.

692 public trials 114 recruiting studies

Refine in advanced search Browse all conditions

Epstein-Barr Virus Infections trial results

Completed

Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction

NCT00054483

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blood Protein Disorders, +74 more
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Study of @neWorld: A Virtual Community for Children With Cancer

NCT00070421

Conditions: Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +27 more
Locations: Leap of Faith Technologies, Incorporated Crystal Lake, Illinois, United States

View Trial Details

Completed

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00060255

Conditions: Amyloidosis, Blast Crisis, Blood Protein Disorders, +84 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

NCT00348985

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +109 more
Locations: University of Colorado Denver, Colorado, United States

View Trial Details

Completed

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

NCT00006368

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +105 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer

NCT00126477

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

NCT00003425

Conditions: Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +74 more
Locations: Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States

Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States

Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

NCT00002552

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +39 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00002908

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

NCT00003956

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Epstein-Barr Virus Infections

Epstein-Barr Virus Infections trial results

Related conditions